BRPI0609044A2 - método e kit de ensaio para a determinação de atividade de timidina cinase em uma amostra biológica, uso de método e/ou de kit de ensaio, método para uso em diagnóstico, monitoração e/ou prognóstico de doenças ou distúrbios de proliferação celular, e método para uso em triagem de compostos - Google Patents

método e kit de ensaio para a determinação de atividade de timidina cinase em uma amostra biológica, uso de método e/ou de kit de ensaio, método para uso em diagnóstico, monitoração e/ou prognóstico de doenças ou distúrbios de proliferação celular, e método para uso em triagem de compostos Download PDF

Info

Publication number
BRPI0609044A2
BRPI0609044A2 BRPI0609044-3A BRPI0609044A BRPI0609044A2 BR PI0609044 A2 BRPI0609044 A2 BR PI0609044A2 BR PI0609044 A BRPI0609044 A BR PI0609044A BR PI0609044 A2 BRPI0609044 A2 BR PI0609044A2
Authority
BR
Brazil
Prior art keywords
kit
biological sample
disorders
assay method
determination
Prior art date
Application number
BRPI0609044-3A
Other languages
English (en)
Inventor
Simon Gronowitz
Original Assignee
Rinnerbol Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rinnerbol Holding Ab filed Critical Rinnerbol Holding Ab
Publication of BRPI0609044A2 publication Critical patent/BRPI0609044A2/pt
Publication of BRPI0609044A8 publication Critical patent/BRPI0609044A8/pt
Publication of BRPI0609044B1 publication Critical patent/BRPI0609044B1/pt
Publication of BRPI0609044B8 publication Critical patent/BRPI0609044B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804Nucleic acid analysis using immunogens

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MéTODO E KIT DE ENSAIO PARA A DETERMINAçãO DE ATIVIDADE DE TIMIDINA CINASE EM UMA AMOSTRA BIOLóGICA, USO DE MéTODO E/OU DE KIT DE ENSAIO, MéTODO PARA USO EM DIAGNóSTICO, MONITORAçãO E/OU PROGNóSTICO DE DOENçAS OU DISTúRBIOS DE PROLIFERAçãO CELULAR, E, MéTODO PARA USO EM TRIAGEM DE COMPOSTOS. São descritos um método e um kit de ensaio para a determinação da atividade de timidina cinase (TK) em uma amostra biológica, tal como sangue, soro, plasma, Fluido Cérebro-Espinhal (CSF), fluido pleural, ascite, tecidos, células e seus extratos. O método compreende contatar com a amostra biológica, em um tampão, uma Mistura Reacional Básica compreendendo: gabarito e/ou iniciador ligado em superficie sólida, um desoxinucleosídeo modificado, tal como Bromo-desóxiUridina, Iodo- desóxiUridina, Fluoro-desóxiUridina ou Vinil-desóxiUridina como um substrato enzima cinase, um doador de fosfato, uma enzima polimerizadora de nucleosídeo, e uma fonte de enzima destituída de atividade de TK, tal como um extrato de levedura. Após a incubação é determinada a quantidade de desoxinucleosídeo modificado que tem sido incorporado no gabarito e/ou iniciador ligado em superficie sólida, e a atividade de TK presente na amostra biológica é diretamente proporcional à quantidade de desoxinucleosídeo modificado incorporado. O método e o kit de ensaio são úteis em diagnóstico, prognóstico, monitoração de progressão de doença e efeitos de tratamento de doenças ou distúrbios de proliferação celular, tal como câncer, e na triagem de compostos, e.g. novos candidatos de droga, afetando vias enzimáticas, que podem obstruir a formação de timidina fosfatos ou interferir com a síntese de ácido nucleico.
BRPI0609044A 2005-02-25 2006-02-24 método e kit de ensaio para a determinação de atividade de timidina cinase em uma amostra biológica, uso de método e/ou de kit de ensaio, método para uso em diagnóstico, monitoramento e/ou prognóstico de doenças ou distúrbios de proliferação celular, e, método para uso em triagem de compostos BRPI0609044B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0500432 2005-02-25
SE0500432-0 2005-02-25
PCT/SE2006/000246 WO2006091158A1 (en) 2005-02-25 2006-02-24 A method and kit for determination of thymidine kinase activity and use thereof

Publications (4)

Publication Number Publication Date
BRPI0609044A2 true BRPI0609044A2 (pt) 2011-08-30
BRPI0609044A8 BRPI0609044A8 (pt) 2017-02-14
BRPI0609044B1 BRPI0609044B1 (pt) 2020-03-10
BRPI0609044B8 BRPI0609044B8 (pt) 2021-07-27

Family

ID=36927697

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0609044A BRPI0609044B8 (pt) 2005-02-25 2006-02-24 método e kit de ensaio para a determinação de atividade de timidina cinase em uma amostra biológica, uso de método e/ou de kit de ensaio, método para uso em diagnóstico, monitoramento e/ou prognóstico de doenças ou distúrbios de proliferação celular, e, método para uso em triagem de compostos

Country Status (21)

Country Link
US (2) US8765378B2 (pt)
EP (1) EP1856275B1 (pt)
JP (1) JP5227034B2 (pt)
KR (1) KR101275585B1 (pt)
CN (1) CN101128600B (pt)
AT (1) ATE439451T1 (pt)
AU (1) AU2006217129B2 (pt)
BR (1) BRPI0609044B8 (pt)
CA (1) CA2598726C (pt)
DE (1) DE602006008435D1 (pt)
DK (1) DK1856275T3 (pt)
EA (1) EA012438B1 (pt)
ES (1) ES2330881T3 (pt)
IL (1) IL185425A (pt)
MX (1) MX2007010334A (pt)
NO (1) NO341196B1 (pt)
NZ (1) NZ556764A (pt)
PL (1) PL1856275T3 (pt)
PT (1) PT1856275E (pt)
WO (1) WO2006091158A1 (pt)
ZA (1) ZA200707334B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9429518B2 (en) * 2010-05-14 2016-08-30 Csens Ab Kit and method
US8728751B2 (en) * 2011-04-12 2014-05-20 Veterinary Diagnostics Institute, Inc. System and method for diagnosing lymphoma in cats
WO2013048952A1 (en) * 2011-09-28 2013-04-04 Biomed Valley Discoveries, Inc. Methods and compositions for detecting infections
CN103728456B (zh) * 2013-09-16 2015-09-30 长沙赢润生物技术有限公司 胸腺嘧啶核苷激酶的elisa诊断试剂盒
CN106556592B (zh) * 2015-09-24 2019-05-21 深圳市安群生物工程有限公司 定量检测人tk1的化学发光试剂盒及其制备方法
ES2983797T3 (es) * 2018-08-31 2024-10-24 Hoffmann La Roche Timidina cinasa (TK-1) en índices pronóstico para LDLBG

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE453514B (sv) 1982-05-14 1988-02-08 Gronowitz Jan Sim0N Sett att bestemma deoxitymidinkinas-dtk-isoenzymnivaer i kroppsvetska eller cellprov och anvendningen av forfarandet for isoenzymtypning
SE462497B (sv) * 1988-11-30 1990-07-02 Clas Fredrik Runesson Kaelland Saett foer att aktivitetsbestaemma polymeraser
KR100396548B1 (ko) * 2001-01-10 2003-09-03 삼성전자주식회사 프린팅 속도를 향상시키는 프린터 제어 장치 및 그 방법
DE60208787T2 (de) * 2001-06-14 2006-11-02 Cavidi Tech Ab Verfahren zum messen der polymerisierung von dna und anwendungen des verfahrens
WO2004011627A2 (en) * 2002-07-25 2004-02-05 David-Nicolas Chaperon A recombinant host cell line screening system for drugs with potential anti-cancer and anti-(retro-) viral activity
ATE352039T1 (de) * 2002-07-27 2007-02-15 Diasorin Ab Verfahren zur bestimmung der aktivität von thymidinkinase-1 und dessen verwendung
DE602004029156D1 (de) * 2003-05-16 2010-10-28 Arocell Ab Prognose des verlaufs einer krebserkrankung
DE102004032872A1 (de) * 2004-07-01 2006-01-19 Bayer Cropscience Ag Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Thymidylat-Kinasen

Also Published As

Publication number Publication date
US8765378B2 (en) 2014-07-01
AU2006217129A1 (en) 2006-08-31
ZA200707334B (en) 2009-02-25
AU2006217129B2 (en) 2011-06-30
IL185425A0 (en) 2008-01-06
US20140255949A1 (en) 2014-09-11
KR20070107055A (ko) 2007-11-06
US20080248472A1 (en) 2008-10-09
EP1856275A1 (en) 2007-11-21
DK1856275T3 (da) 2009-12-07
JP2008531012A (ja) 2008-08-14
US9376707B2 (en) 2016-06-28
BRPI0609044A8 (pt) 2017-02-14
DE602006008435D1 (de) 2009-09-24
CA2598726C (en) 2014-02-18
MX2007010334A (es) 2007-10-10
KR101275585B1 (ko) 2013-06-19
ATE439451T1 (de) 2009-08-15
BRPI0609044B8 (pt) 2021-07-27
PT1856275E (pt) 2009-11-02
EA012438B1 (ru) 2009-10-30
NO341196B1 (no) 2017-09-11
JP5227034B2 (ja) 2013-07-03
CN101128600A (zh) 2008-02-20
EP1856275B1 (en) 2009-08-12
CN101128600B (zh) 2015-12-09
PL1856275T3 (pl) 2010-01-29
BRPI0609044B1 (pt) 2020-03-10
IL185425A (en) 2011-02-28
NO20074882L (no) 2007-11-22
WO2006091158A1 (en) 2006-08-31
NZ556764A (en) 2010-04-30
CA2598726A1 (en) 2006-08-31
EA200701572A1 (ru) 2008-02-28
ES2330881T3 (es) 2009-12-16
HK1117197A1 (zh) 2009-01-09

Similar Documents

Publication Publication Date Title
BRPI0509193B8 (pt) método para diagnosticar doença cervical de alto grau em um paciente, e kit
IL185425A0 (en) A method and kit for determination of thymidine kinase activity and use thereof
US20190017118A1 (en) Method for assessing the risk of complications in patients with systemic inflammatory response syndrome (sirs)
Hamburg et al. Metabolic and diagnostic significance of creatine kinase isoenzymes
FI77895C (fi) Foerfarande foer bestaemning av deoxithymidinkinas-isoentsymaktivitet och dess anvaendning foer diagnosis av sjukdomar.
KR20090025898A (ko) 폐암 환자의 폐암 재발 위험을 예측하기 위한 마커, 키트,마이크로어레이 및 방법
AU2006322316B2 (en) Method for the diagnosis and treatment of cardiovascular diseases
US20190353660A1 (en) Identification of cancer patients sensitive or resistant to 5-fluorouracil (5-fu)
US11560595B2 (en) Method for preventing progression to type II Diabetes
Sadykov et al. Age-and gender-adapted optimization of the qPCR results for estimating telomere length in diagnostics of telomeropathies
MX2008006671A (en) Method for the diagnosis and treatment of cardiovascular diseases
HK1117197B (en) A method and kit for determination of thymidine kinase activity and use thereof
UA64664A (en) Method for predicting course of acute leukemia
HK1127491A (en) Method for the diagnosis and treatment of cardiovascular diseases

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: SOLICITA-SE A REGULARIZACAO DA PROCURACAO, UMA VEZ QUE BASEADO NO ARTIGO 216 1O DA LPI, O DOCUMENTO DE PROCURACAO DEVE SER APRESENTADO NO ORIGINAL, TRASLADO OU FOTOCOPIA AUTENTICADA.

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: PARA QUE A COMPLEMENTACAO APRESENTADA NA PETICAO NO 020110006441/RJ DE 19/01/2011 SEJA ACEITA APRESENTE DOCUMENTO DE PROCURACAO, NAS CONFORMIDADES DO ARTIGO 216 1O DA LPI, PARA O DEPOSITANTE ROENNERBOL HOLDING AB.

B25A Requested transfer of rights approved

Owner name: ROENNERBOL INTERNATIONAL AB (SE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.